For Elanco Animal Health Incorporated [ELAN], Analyst sees a drop to $24. What next?

Elanco Animal Health Incorporated [NYSE: ELAN] plunged by -$0.28 during the normal trading session on Tuesday and reaching a high of $19.195 during the day while it closed the day at $19.08. The company report on August 16, 2022 that Elanco Releases 2021 Environmental, Social and Governance Report Highlighting Progress on Healthy Purpose™ Goals.

Top 5 Cheap Stocks to Own Right Now

While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.

Sign up here to get your free report now. .


Report Aligned with Leading Sustainability Frameworks and Elanco’s Healthy Purpose™ Sustainability Approach.

Elanco Animal Health Incorporated (NYSE:ELAN) today released its 2021 Environmental, Social and Governance (ESG) Report “Changing The World One Animal at a Time” highlighting the company’s progress on relevant ESG topics and metrics.

Elanco Animal Health Incorporated stock has also loss -0.26% of its value over the past 7 days. However, ELAN stock has declined by -18.15% in the 3 months of the year. Over the past six months meanwhile, it has lost -24.07% and lost -32.77% year-on date.

The market cap for ELAN stock reached $8.82 billion, with 488.40 million shares outstanding and 454.53 million shares in the current float. Compared to the average trading volume of 4.68M shares, ELAN reached a trading volume of 8874701 in the most recent trading day, which is why market watchdogs consider the stock to be active.

Here’s what leading stock market gurus have to say about Elanco Animal Health Incorporated [ELAN]:

Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for ELAN shares is $25.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on ELAN stock is a recommendation set at 2.60. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.

JP Morgan have made an estimate for Elanco Animal Health Incorporated shares, keeping their opinion on the stock as Neutral, with their previous recommendation back on August 16, 2022. While these analysts kept the previous recommendation, Goldman dropped their target price from $32 to $19. The new note on the price target was released on July 21, 2022, representing the official price target for Elanco Animal Health Incorporated stock. Previously, the target price had yet another raise to $22, while Piper Sandler analysts kept a Neutral rating on ELAN stock.

The Average True Range (ATR) for Elanco Animal Health Incorporated is set at 0.67, with the Price to Sales ratio for ELAN stock in the period of the last 12 months amounting to 1.90. The Price to Book ratio for the last quarter was 1.31, with the Price to Cash per share for the same quarter was set at 1.10. Price to Free Cash Flow for ELAN in the course of the last twelve months was 20.70 with Quick ratio for the last quarter at 1.50.

ELAN stock trade performance evaluation

Elanco Animal Health Incorporated [ELAN] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -0.26. With this latest performance, ELAN shares dropped by -4.60% in over the last four-week period, additionally sinking by -24.07% over the last 6 months – not to mention a drop of -39.49% in the past year of trading.

Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for ELAN stock in for the last two-week period is set at 40.28, with the RSI for the last a single of trading hit 39.41, and the three-weeks RSI is set at 40.61 for Elanco Animal Health Incorporated [ELAN]. The present Moving Average for the last 50 days of trading for this stock 20.48, while it was recorded at 19.52 for the last single week of trading, and 25.46 for the last 200 days.

Elanco Animal Health Incorporated [ELAN]: An insightful look at the core fundamentals

Operating Margin for any stock indicates how profitable investing would be, and Elanco Animal Health Incorporated [ELAN] shares currently have an operating margin of +6.34 and a Gross Margin at +43.55. Elanco Animal Health Incorporated’s Net Margin is presently recorded at -9.91.

Return on Equity for this stock declined to -5.89, with Return on Assets sitting at -2.76.

Elanco Animal Health Incorporated’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.50 and a Current Ratio set at 2.50.

Earnings per share (EPS) analysis for Elanco Animal Health Incorporated [ELAN] stock

The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for ELAN. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Elanco Animal Health Incorporated go to 13.00%.

Elanco Animal Health Incorporated [ELAN]: Insider Ownership positions

There are presently around $8,952 million, in the hands of institutional investors. The top three institutional holders of ELAN stocks are: DODGE & COX with ownership of 49,206,190, which is approximately 72.124% of the company’s market cap and around 0.30% of the total institutional ownership; VANGUARD GROUP INC, holding 42,476,178 shares of the stock with an approximate value of $810.45 million in ELAN stocks shares; and PRIMECAP MANAGEMENT CO/CA/, currently with $582.92 million in ELAN stock with ownership of nearly -0.756% of the company’s market capitalization.

Positions in Elanco Animal Health Incorporated stocks held by institutional investors increased at the end of August and at the time of the August reporting period, where 222 institutional holders increased their position in Elanco Animal Health Incorporated [NYSE:ELAN] by around 47,891,415 shares. Additionally, 236 investors decreased positions by around 51,612,208 shares, while 69 investors held positions by with 369,688,998 shares. The mentioned changes placed institutional holdings at 469,192,621 shares, according to the latest SEC report filing. ELAN stock had 58 new institutional investments in for a total of 3,270,786 shares, while 85 institutional investors sold positions of 10,363,434 shares during the same period.


Please enter your comment!
Please enter your name here